Iris Eshed
- Rheumatology top 0.2%
- Spondyloarthritis Studies and Treatments 92
- Rheumatoid Arthritis Research and Therapies 55
- Osteomyelitis and Bone Disorders Research 17
-
- Bone and Joint Diseases 49
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 20
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis 12
- Surgery top 5%
- Orthopedic Infections and Treatments 10
- Hip disorders and treatments 10
Iris Eshed
152 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 109
- Rheumatology 2.0k
- Orthopedics and Sports Medicine 722
- Hematology 511
- Immunology 422
- Surgery 720
Countries citing papers authored by Iris Eshed
This map shows the geographic impact of Iris Eshed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Eshed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Eshed more than expected).
Fields of papers citing papers by Iris Eshed
This network shows the impact of papers produced by Iris Eshed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Eshed. The network helps show where Iris Eshed may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Iris Eshed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 18 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 9 | |
| 12 | 2022 | 41 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 18 | |
| 15 | L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients | 2019 | 2 |
| 16 | 2019 | 23 | |
| 17 | 2019 | 44 | |
| 18 | 2018 | 5 | |
| 19 | 2015 | 15 | |
| 20 | Clinical and radiographic outcomes of 139 hips with articular surface replacement total hip arthroplasty*. | 2013 | 3 |
About Iris Eshed
Iris Eshed is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Hematology, having authored 163 papers that have together received 3.0k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (92 papers), Rheumatoid Arthritis Research and Therapies (55 papers), Bone and Joint Diseases (49 papers), Autoimmune and Inflammatory Disorders Research (20 papers), Osteomyelitis and Bone Disorders Research (17 papers), Psoriasis: Treatment and Pathogenesis (12 papers), Orthopedic Infections and Treatments (10 papers) and Hip disorders and treatments (10 papers). The work is most often cited by research in Rheumatology (2.0k citations), Orthopedics and Sports Medicine (722 citations) and Hematology (511 citations). Iris Eshed has collaborated with scholars based in Israel, Denmark and Germany. Frequent co-authors include Kay‐Geert Hermann, Mikkel Østergaard, Merav Lidar, Susanne Juhl Pedersen, Bernd Hamm, Christian E. Althoff, Jakob Møllenbach Møller, M. Bollow, Dvora Aharoni and Ole Rintek Madsen. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Acta Radiologica, Lara D. Veeken and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.